Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia

Br J Haematol. 2016 Sep;174(6):983-5. doi: 10.1111/bjh.13817. Epub 2015 Oct 12.

¹ Unit of Paediatric Haematology and Oncology, Bordeaux University Hospital, Bordeaux-Cedex, France.
² Unit of Paediatric Haematology and Oncology, Armand Trousseau Hospital, Paris, France.
³ Unit of Paediatric Haematology and Immunology, Robert Debré Hospital, Paris, France.
⁴ Institut National de la Santé et de la recherche Médicale (INSERM), Unit754, Registry of Malignant Hemopathies in childhood, Villejuif, France.
⁵ Institute of Paediatric Haematology and Oncology, 1, place du Professeur Joseph Renault, Lyon, France.
⁶ Unit of Paediatric Haematology and Oncology, Hautepierre Hospital, Strasbourg, France.
⁷ Clinical Investigation Centre in Paediatrics CIC 1401, Bordeaux University Hospital, Bordeaux-Cedex, France.
⁸ Unit of Paediatric Haematology and Oncology, Bordeaux University Hospital, Bordeaux-Cedex, France. [email protected].

No abstract available

Keywords: Down syndrome; acute leukaemia; therapy-related mortality; treatment.

Publication types